VerticalNews VerticalNews
VerticalNews VerticalNews VerticalNews VerticalNews     VerticalNews VerticalNews

VerticalNews
Government
Technology
Science
International
Business
Ecology & Environment
Entertainment
Education
VerticalNews
VerticalNews
VerticalNews
VerticalNews

Investment Business Weekly

Welcome to VerticalNews!

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Quest Diagnostics Incorporated



Quest Diagnostics Announces Offering of Common Stock by the Company's Largest Stockholder



February 20th, 2011

Quest Diagnostics Incorporated (NYSE: DGX) announced the underwritten public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of GlaxoSmithKline plc ("GSK"). After giving effect to the proposed offering and the company's repurchase from GSK of 15,377,551 shares of Quest Diagnostics common stock also announced, it is expected that GSK will no longer hold any shares of common stock of Quest Diagnostics.

Quest Diagnostics will not sell any shares of common stock in the offering and will not receive any of the proceeds from the sale of shares in the offering. Quest Diagnostics will pay all...

Click here for more articles from Quest Diagnostics Incorporated


Source: Investment Business Weekly (2011-02-20)

VerticalNews
VerticalNews

VerticalNews
SSL VerticalNews